Certepetide

N/A

Report date: 2024/04/10 09:27:47
NME

Base Information

Drug NameCertepetide
Drug Alias NameInternalized-arginylglycylaspartic acid cyclic peptide (Drugcendr)CEND-1iRGDCIND-1LSTA1 +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeuropilin-1 activators
TargetsNeuropilin-1
Therapy Area/IndicationsNeoplasm MetastasisPancreatic NeoplasmsColonic Neoplasms +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesDrugcendr Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesUniversity Of Iowa PharmaceuticalsGATC Health CorpKuva Labs +[9] 
Inactive CompaniesUniversity Of California San Diego
Active IndicationsPancreatic NeoplasmsColonic NeoplasmsAppendiceal Neoplasms +[7] 
Inactive IndicationsNeoplasm MetastasisColorectal NeoplasmsTriple Negative Breast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A